MarketPeel
Pricing
…
Chief R&D Officer
Bahram Valamehr
Mon, Dec 13, 2021
Dec 13
exercised or converted securities in FATE
25,000 shares @ $2.73
Increased holdings by +16.00%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
FATEFATE THERAPEUTICS INC
HealthcareBiotechnology
1D0.00%
1W-4.67%
1M+1.66%
3M—
6M—
1Y—

Recent insider activity at FATE

Aug 4Bahram ValamehrSold$108.10kAug 4Cindy TahlSold$95.41kMay 20Bahram ValamehrSold$54.48kMay 20Cindy TahlSold$48.08kJan 9Cindy TahlSold$11.28kJan 9Bahram ValamehrSold$5.56kAug 4Cindy TahlSold$9.57kAug 4Bahram ValamehrSold$15.40k
Full FATE profile →Bahram Valamehr’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback